Lineage Reports Second Quarter 2021 Financial Results and Highlights Additional Progress From Clinical Cell Therapy Programs
Go back to Lineage Reports Second Quarter 2021 Financial Results and Highlights Additional Progress From Clinical Cell Therapy Programs| (NYSE: LCTX) | Delayed: 1.27 +0.01 (0.79%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.26 | 52 Week High | $ | |||
| Open | $1.24 | 52 Week Low | $ | |||
| Day High | $1.29 | P/E | N/A | |||
| Day Low | $1.24 | EPS | $ | |||
| Volume | 491,073 | |||||
| (NYSE: LCTX) | Delayed: 1.27 +0.01 (0.79%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.26 | 52 Week High | $ | |||
| Open | $1.24 | 52 Week Low | $ | |||
| Day High | $1.29 | P/E | N/A | |||
| Day Low | $1.24 | EPS | $ | |||
| Volume | 491,073 | |||||

